Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

13. Januar 2014 07:00 ET | Quelle: Stem Cell Therapeutics Corp.

Stem Cell Therapeutics Provides Corporate Update

TORONTO, ONTARIO--(Marketwired - Jan. 13, 2014) - Stem Cell Therapeutics Corp. (TSX VENTURE:SSS)(OTCQX:SCTPF), an immuno-oncology company developing cancer stem cell-related therapeutics,...
17. Dezember 2013 07:00 ET | Quelle: Stem Cell Therapeutics Corp.

Stem Cell Therapeutics Appoints Dr. Robert Kirkman to Its Board of Directors

TORONTO, ONTARIO--(Marketwired - Dec. 17, 2013) - Stem Cell Therapeutics Corp. (TSX VENTURE:SSS)(OTCQX:SCTPF), an immuno-oncology company developing cancer stem cell-related therapeutics,...
13. Dezember 2013 16:49 ET | Quelle: Stem Cell Therapeutics Corp.

Stem Cell Therapeutics Completes $33 Million Private Placement

TORONTO, ONTARIO--(Marketwired - Dec. 13, 2013) - Stem Cell Therapeutics Corp. (TSX VENTURE:SSS)(OTCQX:SCTPF), an immuno-oncology company developing cancer stem cell- related...
05. Dezember 2013 07:00 ET | Quelle: Stem Cell Therapeutics Corp.

Stem Cell Therapeutics to Provide Update on CD47 Program at the 2013 Annual Meeting of the American Society of Hematology

TORONTO, ONTARIO--(Marketwired - Dec. 5, 2013) - Stem Cell Therapeutics Corp. (TSX VENTURE:SSS) (OTCQX:SCTPF), an immuno-oncology company developing cancer stem cell-related therapeutics,...
31. Oktober 2013 07:00 ET | Quelle: Stem Cell Therapeutics Corp.

Stem Cell Therapeutics Receives U.S. Orphan Drug Designation for the Use of Tigecycline to Treat Acute Myeloid Leukemia

TORONTO, ONTARIO--(Marketwired - Oct. 31, 2013) - Stem Cell Therapeutics Corp. (TSX VENTURE:SSS)(OTCQX:SCTPF), an immuno-oncology company developing cancer stem cell-related therapeutics,...
17. Oktober 2013 07:00 ET | Quelle: Stem Cell Therapeutics Corp.

Stem Cell Therapeutics Strengthens CD47 Franchise With Acquistion of Complementary Antibody Program

TORONTO, ONTARIO--(Marketwired - Oct. 17, 2013) - Stem Cell Ther apeutics Corp. (TSX VENTURE:SSS)(OTCQX:SCTPF), a biopharmaceutical immuno-oncology company developing cancer stem...
17. September 2013 07:00 ET | Quelle: Stem Cell Therapeutics Corp.

Stem Cell Therapeutics Adopts Shareholder Rights Plan

TORONTO, ONTARIO--(Marketwired - Sept. 17, 2013) - Stem Cell Therapeutics Corp. (TSX VENTURE:SSS)(OTCQX:SCTPF), a biopharmaceutical company developing cancer stem cell-related...
09. September 2013 07:00 ET | Quelle: Stem Cell Therapeutics Corp.

Stem Cell Therapeutics Advances CD47 Antagonist Program Into IND-Enabling Phase

TORONTO, ONTARIO--(Marketwired - Sept. 9, 2013) - Stem Cell Therapeutics Corp. (TSX VENTURE:SSS)(OTCQX:SCTPF), a biopharmaceutical company developing cancer stem cell- related...
06. September 2013 07:00 ET | Quelle: Stem Cell Therapeutics Corp.

Stem Cell Therapeutics Announces Participation at the 15th Annual Rodman & Renshaw Global Investment Conference in New York City September 8-10th

TORONTO, ONTARIO--(Marketwired - Sept. 6, 2013) - Stem Cell Therapeutics Corp. (TSX VENTURE:SSS)(OTCQX:SCTPF), a biopharmaceutical company developing cancer stem cell-related...
09. August 2013 07:00 ET | Quelle: Stem Cell Therapeutics Corp.

Stem Cell Therapeutics Acquires an Exclusive Option to License Prostate Cancer Stem Cell Assets

TORONTO, ONTARIO--(Marketwired - Aug. 9, 2013) - Stem Cell Therapeutics Corp. (TSX VENTURE:SSS)(OTCQX:SCTPF), a biopharmaceutical company developing cancer stem cell-related therapeutics,...

Vorherige Seite

Nächste Seite